Advanced search
Publication Cover
Vascular Health and Risk Management Volume 9, 2013 - Issue
Submit an article Journal homepage
95
Views
3
CrossRef citations to date
0
Altmetric
Review

Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update

Yukiomi Tsuji1 Institute of Pharmacology, Faculty of Medicine, University Duisburg-Essen, Essen
&
Dobromir Dobrev1 Institute of Pharmacology, Faculty of Medicine, University Duisburg-Essen, Essen;2 Division of Experimental Cardiology, Medical Faculty Mannheim, Heidelberg University, Mannheim;3 Deutsches Zentrum für Herz-Kreislauf-Forshcung [German Center for Cardiovascular Research], partner site Heidelberg/Mannheim, Mannheim, GermanyCorrespondence[email protected]
Pages 165-175 | Published online: 23 Apr 2013

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Birgit T Priest & Jeff S McDermott. (2015) Cardiac ion channels. Channels 9:6, pages 352-359.
Read now
Richard A Brown, Yee Cheng Lau & Gregory YH Lip. (2014) Vernakalant hydrochloride to treat atrial fibrillation. Expert Opinion on Pharmacotherapy 15:6, pages 865-872.
Read now
Bharat Narasimhan, Kruti Gandhi, Errol Moras, Lingling Wu, Akanibo Da Wariboko & Wilbert Aronow. Experimental drugs for supraventricular tachycardia: an analysis of early phase clinical trials. Expert Opinion on Investigational Drugs 0:0.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.